focus -WSS

focus

author：focus 2025-09-29 01:39:17 - browse：79272

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Apple is now the first public company to be valued at $3 trillion

focus

knowledge

WSS

Obesity drugs seen as possible treatment for liver disease MASH

Virginia high school admissions case could be legal follow

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

NIH study of ME/CFS points to clear biological hallmarks

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

focus

focus

hotspot

How to save PrEP access — and even expand it

Dario to buy mental health app maker Twill in cash and stock deal

Duchenne breakthrough therapy leaves behind pioneering families

In utero gene editing: an explainer

Hollywood unions extend contract negotiations for actors

Peter Hotez and the public health issue of online harassment

ChatGPT in medicine: STAT answers readers' burning questions

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Novavax promises a turnaround & Lilly roils the obesity market

In utero gene editing: an explainer

knowledge

New documents shed light on MD Anderson Cancer Institute feud

After affirmative action ruling, medical educators look to 'holistic review'

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT readers on older presidents, polypills, Medicare, and more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Duchenne breakthrough therapy leaves behind pioneering families

focus

knowledge

entertainment

focus